• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of Fast Track designation requests granted

Dictionary: Fast track is an expedited drug development and review program for new drugs or biologics intended to treat serious or life-threatening conditions that demonstrate the potential to address unmet medical need.

Information is current as of December 31, 2013.

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetNumber
Oct 2012N/A5
Nov 2012N/A5
Dec 2012N/A12
Jan 2013N/A11
Feb 2013N/A11
Mar 2013N/A4
Apr 2013N/A7
May 2013N/A3
Jun 2013N/A5
Jul 2013N/A2
Aug 2013N/A4
Sep 2013N/A6

FY 2013 Total: 75

Footnotes

  • CDER created new measures and began collecting data in July 2012. Therefore, FY12 will only include 3 months of data.

Number of applications approved under Accelerated Approval

Dictionary: Accelerated Approval is a regulatory pathway that allows for approval of drugs intended to treat serious or life-threatening diseases and that provide meaningful therapeutic benefit to patients over existing therapies, based on the use of surrogate endpoints reasonably likely to predict clinical benefits or a clinical endpoint other than survival or irreversible morbidity. (See also 21 CFR 314 Subpart H and 601 Subpart E)

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetNumber
Oct 2012N/A1
Nov 2012N/A0
Dec 2012N/A2
Jan 2013N/A0
Feb 2013N/A1
Mar 2013N/A0
Apr 2013N/A0
May 2013N/A0
Jun 2013N/A0
Jul 2013N/A0
Aug 2013N/A0
Sep 2013N/A0

FY 2013 Total: 4

Number of First Generics approved

Dictionary: The first time that a particular drug is approved in generic form.

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetNumber
Oct 2012N/A6
Nov 2012N/A9
Dec 2012N/A16
Jan 2013N/A8
Feb 2013N/A7
Mar 2013N/A16
Apr 2013N/A7
May 2013N/A9
Jun 2013N/A4
Jul 2013N/A18
Aug 2013N/A9
Sep 2013N/A10

FY 2013 Total: 120

Number of orphan drugs addressing rare diseases approved

Dictionary: Orphan drugs are products intended for the safe and effective treatment of rare diseases/disorders that affect fewer than 200,000 U.S. patients.

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetNumber
Oct 2012N/A1
Nov 2012N/A1
Dec 2012N/A6
Jan 2013N/A1
Feb 2013N/A2
Mar 2013N/A1
Apr 2013N/A2
May 2013N/A1
Jun 2013N/A3
Jul 2013N/A1
Aug 2013N/A2
Sep 2013N/A1

FY 2013 Total: 22

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.